Oppenheimer Issues Positive Forecast for The Ensign Group (NASDAQ:ENSG) Stock Price

The Ensign Group (NASDAQ:ENSG) had its price target raised by stock analysts at Oppenheimer from $210.00 to $215.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer‘s price target points to a potential upside of 16.78% from the company’s previous close.

Other analysts also recently issued reports about the stock. Wall Street Zen upgraded shares of The Ensign Group from a “hold” rating to a “buy” rating in a report on Sunday. Truist Financial set a $210.00 target price on shares of The Ensign Group in a report on Thursday. Weiss Ratings upgraded shares of The Ensign Group from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $228.00 target price on shares of The Ensign Group in a research report on Tuesday, July 28th. Five research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $216.60.

The Ensign Group Stock Up 8.6%

Shares of The Ensign Group stock opened at $184.11 on Thursday. The business’s 50 day simple moving average is $174.68 and its 200 day simple moving average is $181.50. The Ensign Group has a 52-week low of $141.58 and a 52-week high of $218.00. The firm has a market cap of $10.73 billion, a PE ratio of 28.86, a P/E/G ratio of 1.66 and a beta of 0.66. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.21 and a current ratio of 1.21.

The Ensign Group (NASDAQ:ENSG) last released its earnings results on Tuesday, October 27th. The company reported $2.03 EPS for the quarter, beating the consensus estimate of $1.97 by $0.06. The Ensign Group had a return on equity of 16.75% and a net margin of 6.90%. The firm had revenue of $1.48 billion for the quarter, compared to analysts’ expectations of $1.51 billion. During the same quarter in the previous year, the business posted $1.64 EPS. The business’s quarterly revenue was up 14.5% compared to the same quarter last year. On average, analysts predict that The Ensign Group will post 7.04 earnings per share for the current fiscal year.

Hedge Funds Weigh In On The Ensign Group

Several hedge funds and other institutional investors have recently made changes to their positions in the company. BlackRock Inc. bought a new stake in The Ensign Group during the second quarter worth $937,218,000. Wasatch Advisors LP increased its stake in shares of The Ensign Group by 10.7% during the 2nd quarter. Wasatch Advisors LP now owns 2,278,324 shares of the company’s stock worth $365,215,000 after purchasing an additional 220,329 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in shares of The Ensign Group by 7.1% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 457,667 shares of the company’s stock valued at $92,220,000 after purchasing an additional 30,521 shares during the period. Bank of New York Mellon Corp bought a new stake in shares of The Ensign Group in the 2nd quarter valued at about $65,470,000. Finally, Paradigm Capital Management Inc. NY bought a new stake in shares of The Ensign Group in the 2nd quarter valued at about $54,742,000. 96.12% of the stock is owned by institutional investors.

Key Headlines Impacting The Ensign Group

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Ensign reported third-quarter adjusted earnings of $2.03 per share, exceeding consensus estimates near $1.94–$1.97 and rising from $1.64 a year earlier. Revenue increased 14.5% year over year to approximately $1.48 billion. Ensign Group third-quarter results
• Positive Sentiment: The company raised its 2026 annual earnings guidance, while UBS analyst A.J. Rice reiterated a Buy rating, citing strong operating trends and continued earnings-growth potential. UBS analyst rating
• Neutral Sentiment: Several law firms reminded investors of a December 7, 2026 deadline to seek lead-plaintiff status in a securities class action covering investors who purchased ENSG shares from February 10, 2022, through June 18, 2026. These notices largely repeat previously reported litigation developments rather than represent new operating news. Rosen securities lawsuit notice
• Negative Sentiment: A securities-fraud class action alleges that Ensign and certain executives concealed patient neglect, understaffing, manipulated quality and staffing data, improper billing, and an administrator-license rental scheme. The allegations followed reports and an approximately 8% stock decline, increasing legal, reputational, and potential financial risks. The claims have not been proven. BFA Law Ensign securities-fraud lawsuit notice

The Ensign Group Company Profile

The Ensign Group, Inc is a healthcare services company that provides skilled nursing, post-acute care and rehabilitation services. Its facilities serve patients recovering from illness, injury or surgery, as well as individuals requiring long-term nursing care and support with daily living.

Through its operating subsidiaries, Ensign also provides assisted living and other senior care services. Its portfolio includes skilled nursing facilities, senior living communities and related healthcare operations, with services such as physical, occupational and speech therapy, medically complex care and rehabilitation.

Founded in 1999 and headquartered in San Juan Capistrano, California, The Ensign Group operates healthcare facilities across multiple U.S.